Quest Diagnostics/$DGX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Quest Diagnostics

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Ticker

$DGX
Sector

Primary listing

NYSE

Employees

50,500

DGX Metrics

BasicAdvanced
$21B
22.01
$8.35
0.49
$3.10
1.74%

What the Analysts think about DGX

Analyst ratings (Buy, Hold, Sell) for Quest Diagnostics stock.

DGX Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DGX Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DGX

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Oct3
Quest Diagnostics
Dividend·Ex-dividend
Oct20
Quest Diagnostics
Dividend·Payment
$0.80Per share
FAQs